Cas No.: | 1869057-83-9 |
Chemical Name: | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide |
Synonyms: | AST2818;AST-2818;ASK120067 |
SMILES: | C(NC1=CC(NC2=NC=CC(C3C4=C(N(C)C=3)C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(CCN(C)C)C)(=O)C=C |
Formula: | C28H31F3N8O2 |
M.Wt: | 568.605 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation. Lung Cancer Phase 1 Clinical |